Carregant...
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
Immunotherapy has revolutionized the treatment of cancer. Nevertheless, the majority of patients do not respond to therapy, meaning a deeper understanding of tumor immune evasion strategies is required to boost treatment efficacy. The vast majority of immunotherapy studies have focused on how treatm...
Guardat en:
| Publicat a: | Front Immunol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7538772/ https://ncbi.nlm.nih.gov/pubmed/33072137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.589641 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|